Skip to main content
An official website of the United States government
Email

Launch of the WHO Collaborating Center for Global Cancer Control

Group of WHO and NCI colleagues standing together on a set of stairs Enlarge

WHO and NCI colleagues at the launch of the WHO Collaborating Center for Global Cancer Control re-designation on June 18, 2024. 

On June 18, 2024, the Center for Global Health (CGH) welcomed a World Health Organization (WHO) delegation to the National Cancer Institute (NCI) for the launch of the third re-designation of the NCI WHO Collaborating Center (WHOCC) for Global Cancer Control. The re-designation of the NCI WHOCC for Global Cancer Control renews the efforts of an eight year partnership with WHO, to strengthen health systems and improve outcomes related to global cancer control. 

The launch served as a forum to discuss shared priorities between CGH and the WHO's Department of Noncommunicable Diseases; celebrate the accomplishments of the first eight years of the WHOCC for Global Cancer Control; and reaffirm the focus and goals of this third designation period (2024-2028). We were pleased to welcome colleagues from WHO and other USG offices to partake in this significant re-designation:

  • Dr. W. Kimryn Rathmell, Director, National Cancer Institute
  • Dr. Satish Gopal, Director, Center for Global Health, National Cancer Institute 
  • Dr. Ophira Ginsburg, Senior Scientific Advisor for Clinical Research, Center for Global Health, National Cancer Institute
  • Dr. Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases 
  • Dr. Christopher Fitzpatrick, WHO Executive Officer, Office of the Assistant Director-General for Universal Health Coverage, Communicable and Noncommunicable Diseases 
  • Mr. Stewart Simonson, Assistant Director-General, WHO Office at the United Nations  
  • Dr. Bente Mikkelsen, Director, Department of Noncommunicable Diseases, Rehabilitation and Disability 
  • Dr. Meg Doherty, Director, Department of HIV, Hepatitis, and STIs 
  • Mr. Andrew Seale, Advisor, Department of HIV, Hepatitis, and STIs 
  • Dr. André Ilbawi, Head, Cancer Unit
  • Dr. Olga Cabello Henry, Senior Advisor, Regional and Multilateral Diplomacy, U.S. Department of State
Email